RLMD · Relmada Therapeutics, Inc.
$4.80
+0.05 (+1.05%)
At close · Aug 14
Market Cap
$512.02M
Shares
106.67M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1553643
CUSIP
75955J402
13F (30d)
126 filings
124 filers
Visit website
Investor relations